We hear increasingly about the importance of tackling overtreatment, but less often about how overtreatment plays out in the lives of patients and their families. In the article below, Brook... Read more
Last night (23 March) Australia’s deputy chief medical officer, Dr Paul Kelly, said that new protocols determining who can be tested for the virus that causes COVID-19 will be announce... Read more
Introduction by Croakey: Low-value healthcare is defined as that which “provides little or no benefit, may cause patient harm, or yields marginal benefits at a disproportionately high cost”.... Read more
A Queensland Government health service’s success in reducing unnecessary pathology testing will be among a number of programs showcased at a national meeting in Melbourne today to mark the s... Read more
In this fourth article in our Choosing Wisely series, Dr Lynn Weekes AM, CEO of NPS MedicineWise looks at how lists of five things can really change the conversation about low value health... Read more
In the third of a series of articles that Croakey is running on the Choosing Wisely campaign (see the other two here and here), Professor Jon Karnon highlights the role of health services re... Read more
The evidence suggest the harms of population screening for prostate cancer outweigh the benefits, so why does it remain so popular? It’s a complex issue, particularly for GPs who are o... Read more
In his latest post for Croakey, The Naked Doctor, Justin Coleman, previews the Choosing Wisely campaign, due to launch in Australia in April. This campaign focuses on cutting down the numbe... Read more
An important campaign has just been launched in the US, with the backing of nine medical societies and several consumer groups, to encourage doctors and patients to identify tests and treatm... Read more
As has been widely reported, the US Preventive Services Task Force has issued a draft recommendation that the prostate-specific antigen (PSA) test should not be used to screen for prostate c... Read more
